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Synthesis of 3-Aminopyrrolidin-2-ones by an Intramolecular eaction of 
Aziridinecarboxamides. 
Ikuo Funaki, Lambertus Thijs and Binne Zwanenburg* 
Department of Organic Chemistry, NSR Center for Molecular Structure, Design and Synthesis, University of Nijmegen, 
Toernooiveld, 6525 ED Nijmegen, The Netherlands 
Abstract: The synthesis of 4,5-disubstituted-3-amino-7-1actams from N-substituted aziridinecarbox- 
amides i described. Bicyclic aziridine derivatives were obtained from 1-N-Boc-aziridinecarboxamides un r 
kineucally controlled conditions. Oxiranecarboxamides showed similiar behavior and gave 3-hydroxy- 
lactams. Copyright © 1996 Elsevier Science Ltd 
INTRODUCTION 
Conformationally restricted ipeptide mimics have received extensive attention for the study of the 
relationships between biological activity, selectivity and peptide structures. 1 The utilization of 3-amino-~'-,8-and 
~-lactams i of special interest in this context, lp, 2a Lactams are considered to provide a rigid structural unit in the 
backbone system of the mimics. Several research groups have designed lactam-bridged dipeptides e.g. 1 as 
conformationally restricted inhibitor mimics. 2,3 
R 1 R 2 
amino acid~ * ~  
N,~N~ amino acid 
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Most of the substituted 7-1actam rings reported were prepared in a stereospecific manner from the 
corresponding amino acids. These strategies often suffer from racemization atthe stereogenic centers, or only 
allow a limited variation of substituents. To investigate structure-activity relationships, ynthetic methods 
producing tactams from non-natural chiral sources are desired, because those methods would allow a more 
precise design of mimics. In this paper, the synthesis of 4,5-disubstituted 3-amino-~,-lactams 2 is reported, using 
intramolecular ziridine ring-opening reactions, whereby the chirality is transferred from the aziridine ring to the 
ring-expanded heterocycle (Scheme 1). 
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The required aziridines are available by the methods used and (partly) developed in the Nijmegen 
laboratory. 4 Since enantiopure aziridinecarboxamides 5 can be prepared readily from enantiopure oxirane- 
carboxylic esters whose synthesis has been well established, 4,5the strategy shown in Scheme 1 allows the 
preparation of various highly-substituted 7-1actams. In addition, it should be noted that intramolecular ring- 
opening reactions of aziridines have been scarcely studied 6,7,8 in contrast to intermolecular reactions. 9,10 It is 
also of interest to compare intramolecular ring-opening reactions of aziridines with those of the corresponding 
epoxides. 
RESULTS and DISCUSSION 
Activated aziridinecarboxamides 4 and 5 were prepared from aziridinecarboxylic esters 3 as shown in 
Scheme 2. Literature reports suggest that strong activation of the aziridine-ring system may be necessary to 
accomplish the desired ring-opening reactions. 4,9 Therefore, 4-tolylsulfonyl (Ts) and tert-butoxycarbonyl (Boc) 
groups were introduced onto the aziridine nitrogen atom. Diethyl aminomalonate was chosen as the amine moiety 
of the carboxamides because the 'soft' nucleophilic haracter of malonyl carbanions was expected to be 
appropriate for the rather 'soft' aziridine ring carbons. After either the Ts or the Boc group was introduced, the 
activated aziridines were hydrolysed with LiOH/H20, followed by DCC/HOBT condensation to afford 
aziridinecarboxamides 4 and 5 in high overall yields. 
EWG 
I 
NH C6H13 "~N~ 
06H13 ~j  ~ a,c,d ~ ~ O  4; EWG =- SO2Tol (Ts) (overall 91%) 
\ or b,c,d 5; EWG = -CO2t-Bu (Boc) (overall 81%) 
3 CO2Et N H 
~COOEt 
COOEt 
Reagents and Conditions: (a) (t-Boc)20, DMAP, CH2CI2; (b) TsCI, Et3N, DMAP, CH2CI2; (c) LiOH, 
H20, THF; (d) DCC, diethyl aminomalonate, 1-hydroxybenzotriazole (HOBT), EtOAc. 
Scheme 2 
Treatment of (rac., trans) tosyl-activated aziridinecarboxamide 4 with a catalytic amount of sodium ethoxide 
in absolute thanol at room temperature produced pyrrolidinone 6 in high yield (Scheme 3). The same product 
was isolated when substrate 4 was treated with LDA in THF or pyridine in chloroform, albeit in much lower 
yields. 
The product 6 was proven to have a five-membered ring system by NMR proton-decoupling analysis. It 
was impossible, however, to determine the relative configurations at C-3 and C-4 from the coupling constants. 
Therefore an X-ray crystallographic analysis was performed which showed unambiguously the relative 
stereochemistry in 6 to be trans as shown in Figure 1.11 The formation of this five-membered heterocycle 6
clearly takes place by an intramolecular substitution reaction with inversion of configuration atthe C-3 of the 
starting aziridine. 
Ts 
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06H13 se° A 
" - - '~0  
EtO2C--r" N H 
4 CO2Et 
C6H13 NHTs 
base Et02C~ 0 
r EtO2C 
6 
Scheme 3
Entry Reaction conditions Yield (%) 
1 cat. NaOEt/EtOH 88 
rt, overnight 
2 1.1 eq. LDA/THF 31 
-78 °C to rt, overnight 
3 excess pyridine/CHCI3 40 
rt, overnight 
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Figure 1. X-ray diffraction analysis of pyrrolidinone 6. 
The optimum conditions for intramolecular ring opening (i.e., catalytic NaOEt/EtOH) were also applied to 
the Boc-activated aziridinecarboxamide 5. This reaction resulted in the formation of pyrrolidinone 7 in 78% yield 
as a single isomer (Scheme 4). NMR analysis howed that the product 7 is a five-membered heterocycle. 
C6H13 NHBoc 
 t° Cc it, overnight O 
EtO2 N 
7(78%) 
Boc 
I 
C6H13 ~%. ,~O 
N H 
EtO2C / 
CO2Et 
i) 2.2 eq. LDNTHF; 
-78°0,0.5h ~L_ ~ CO2Et 
ii) 0°C, 2.5h /~N CO Et 
06H13 N 2 
s ,,22.v  ° 
Scheme 4 8 (73 %) 
In contrast, an unexpected result was obtained when substrate $ was treated under kinetically controlled 
reaction conditions (LDA in THF at 0 °C), namely the formation of the bicyclic aziridine 8 in high yield (73%). 
Interestingly, the aziridine moiety is retained in this product and an acyl substitution atthe Boc has taken place. 
Some more examples of this type of bicyclic aziridines are collated in Table 1. 
The thermodynamically controlled reaction conditions (NaOEt in EtOH at room temperature) of these 
intramolecular reactions caused abstraction of the malonyl proton, leading to attack at C-3 of the aziridine ring 
(Scheme 4). Under kinetically controlled reaction conditions (LDA in THF at 0 °C), however, LDA abstracted the 
proton attached to the amide-nitrogen, a d the anion generated thus is 'hard' enough not to attack at the 'soft' 
aziridine-ring carbons but at the 'hard' carbonyl carbon. 12 In all of the entries given in Table 1, aziridine ring- 
opening reactions did not occur since the nitrogen-anion did not attack the aziridine ring carbons. 
The synthesis of 3,4-cis-pyrrolidinone was then investigated in order to confirm the stereochemistry of the 
pyrrolidinone 7 since the measurement of 1H-NMR coupling constants was not possible. The cis- 
aziridinecarboxamide 17 derived from the cis-aziridinecarboxylate disappointingly failed to react under the 
standard conditions of this method (Scheme 5). It is assumed that the hexyl group on aziridine C-3 interferes 
substantially with the bulky malonyl group; and the same interference ould explain the absence of C-2 ring- 
carbon attack leading to an azetidinone.l 3a In comparable oxiranecarboxamide systems intramolecular attack has 
been observed at the C-2 position, albeit only with a methyl as alkyl substituent. 13b-f 
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Table 1 
O~10-t-Bu 
"~NH-R '  
O 
O 
base ~ R~oN_  R, 
Entry Substrate R R' Reaction Conditions Yield (%) Product 
1 5 Hex CH(CO2Et)2 2.2 eq. LDA/THF; 73 8 
-78 °C, 05h, 0 °C, 2.5h 
2 9 Bu CH2C(O)Ph cat. t-BuOK, rrHF; 99 13 
rt, 6h 
3 10 Hex CH2CO2Me cat NaOMe/MeOH; 52 14 
rt, overnight 
4 11 Hex CH2Ph cat t-BuOK/THF; 65 15 
rt, overnight 
5 12 PhCH2 CH2C(O)Ph cat t-BuOK/THF; 87 16 
0 °C, 3.5h, rt, 2.5h 
Another approach to a cis sustituted pyrrolidinone was more successful. Intermolecular ring-opening 
reactions of aziridines have been investigated xtensively. 9,10 Hydriodic acid is known to react with activated 
aziridinecarboxamides, 9  where iodide attacks electively at C-3. Following the introduction of iodine in an SN2 
fashion, it may be substituted through subsequent attack of malonyl carbanions. When N-Boc- 
aziridinecarboxamide 5 was treated with hydriodic acid in acetone for 3h at 0 oC, followed by the ring-closure 
conditions (1.5 eq. NaOEt/EtOH), iodide opened the aziridine ring and then participated as a leaving roup 
(Scheme 6). The reaction presumably proceeded through double inversion leading to the 3,4-cis-pyrrolidinone 
18, together with the 3,4-trans-pyrrolidinone 7 (15% yield). The trans-pyrrolidinone 7 may have been produced 
through the direct intramolecular reaction of unreacted starting material 5 (according to Scheme 4) without he 
assistance of iodide. 
O O 
~-~ ¢" "os,,fO H ~ C H '~'" "os 06H1"3 "~" C6H13 6 13 CO2Me 
Boc 
N H I C6H13 NH-Boc 
~66H13 "CO2Me C6H13 O EtO2C '~' 
H 
Et02C--~ NH 17 18 
CO2Et 
Reactions and Reagents: (a) Sharpless epoxidation; (b) Ru cat., NalO4; (c) Diazomethane; (d) NaN 3, 
NH4CI/EtOH; (e) PPh3; (f) di-t-Butoxy-dicarbonate, DMAP; (g) aq. LiOH/'I'HF; (h) Diethyl aminomalonate, 
DCC/EtOAc; (i) cat. NaOEt/EtOH 
Scheme 5
The pyrrolidinones 7 and 18 were subjected to 2D-NOESY NMR analysis in order to confirm the 
1 14 configuration f 3,4-trans- and c's-N-Boc-pyrrolidinones. C4-H of 7 showed interaction with the N-H of the 
carbamoyl group. Contrastingly the C4-H of 18 did not interact with the N-H of the carbamoyl function but 
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instead interacted with C3-H. These observations support the assigned structure, namely, the pyrrolidinone 7 has 
a 3,4-trans configuration, whilst in the pyrrolidinone 18 this is cis. 
Boc 
i NH-Boc C6H13 NH-Boc 
" %  06H13 ~,~ 0 , ~  06H13 % 
O leq. HI "~" 7" 1.5eq. NaOEt EtO2C O 
I NH 
EtO2C~,N H acetone"~0 °C. 3h I~CO2Et EtOH, rt EtO2C H';' 
EtO2 C" 5 CO2 Et 
18 (16% overall yield) 
Scheme 6
The new methodology shown in Schemes 3 and 4 was also applied to the synthesis of 3- 
hydroxypyrrolidinone. As anticipated from the reported result of a similar epoxide ring-opening reaction, 15 
intramolecular reaction of the oxiranecarboxamide analogue 19 took place in the same manner as for 
aziridinecarboxamides. When the epoxide analogue 19 was treated with a catalytic amount of sodium ethoxide in 
ethanol, pyrrolidinone 21) was obtained (Scheme 7). 
C6H13% ?~;:;O o. 
i) hydrolysis 
C6H13 r3 s,,../~ ii) DCC coupling 
%CO2Me }D, EtO2c~NH 
CO2Et 
19 (87%) 
cat. NaOEt 
EtOH 
rt, overnight 
04H9 t,,,,. ? ~  
?~,  C.~COaEt DeC ~ O NaOEt 04H9 *'e#,.. + H coupling v
--CO2H CO2Et EtO 2 C ,,,,.7.,.~ N...., C H 3 EtOH 
EtO2C 21 (38%) 
C6H~ 0 H 
EtO2C~o 
EtO2 
H 
20 (-18"1o) 
C4H 9 OH 
Et02C~o 
EtO2C" I~ 
CH3 22 (93%) 
Scheme 7
Substitution of nitrogen in the oxiranecarboxamide with a methyl group as in 21 did not change the 
outcome of the reaction, again a pyrrolidinone e.g. 22 was obtained. Although the aziridine analogue of 21 could 
not be prepared ue to the difficulty of the amide-bond forming reaction, the result of 21 is indicative of the 
reaction of the corresponding aziridinecarboxamide, since the reaction characteristics are virtually the same. 
The aziridinecarboxamides 4 and 5 carry two ester units in the malonyl moiety. The synthetic scope of the 
intramolecular ring opening would improve if such a reaction could also be performed with an 
aziridinecarboxamide containing only one ester function. Such a substrate, i.e. 23 could be prepared by a DCC 
coupling of an aziridinecarboxylic a id and N-benzylglycine methyl ester. Treatment of substrate 23 with 
potassium t-butoxide in THF resulted in the formation of azetidinone 24, albeit in low yield (19%), together with 
unreacted 23 (Scheme 8). With LDA the yield was even lower (7%). No five-membered ring product could be 
detected, although for the tosyl-activated aziridine ring an intramolecular reaction at C-3 would have been 
expected.16 Other bases, such as Triton B and sodium bis(trimethylsilyl)amide yielded no cyclization products. 
Interestingly, azetidinone 24 has the cis configuration as was deduced from the coupling constant for H-3 and H- 
4 in the IH-NMR spectrum. A satisfactory explanation for this stereochemical outcome cannot be given yet. 
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ms 
I NH-Ts 
EtO2C4k, 
C6H13'~"°'?~.~O t-BuOK, THF ~r C6H13 
O°C, overnig., B N,_~K. 0 
~..--" N-, B n 
23 CO2Et 24 (19%) 
Scheme 8
The aziridinecarboxamide 25 corresponding to 23 but without he N-benzyl group, was also prepared. 
However, base treatment only led to decomposition products. 
The failure of these cyclization reactions prompted us to try alternative methods, uch as a decarboxylation 
reaction. 
Although pyrrolidinone 7 could not be converted into the corresponding monoethoxycarbonyl p rrolidinone 
26 by treatment with NaCI-H20-DMSO, 17 it was obtained by employing LiBr-H20-1,3-dimethyl-2- 
imidazolidinone (DMI; 155 oC, 4h) 18 (Scheme 14). The product was a 1:1 inseparable mixture of C-5 isomers 
which could be analyzed by 1H-NMR spectroscopy. When the same procedure was applied to the pyrrolidinone 
6, mono-de-ethoxycarbonylation was also achieved and the two C-5 isomers 27a/27b formed were readily 
separated by column chromatography. Unfortunately, anattempt to determine the stereochemistry of the two 
isomers 27a/27b y 2D-NOESY 1H NMR analysis failed to provide a clear answer. 
C6H13 NH-Boc C6H13 NH-Boc 
. ~  LiBr'H20"DMI ~. , ~  
EtO2C O 155 °C; 4h Y EtO2C O 
EtO2C I I 
H 7 H 26 (64 %) 
06H13 NH-Ts 06H13 NH-Ts ~ 06H13 NH-TS 
LiBr-H20-DMI EtO2C"~N4I~O o ~ and EtO2C 
EtO2C I 155 C; 4h Et H I 
H 6 H 27~¢b (42 %) H 
Scheme 9
CONCLUSION 
In conclusion, a novel synthetic strategy for the preparation of 3-amino-4-hexyl-5-ethoxycarbonyl- 
pyrrolidin-2-ones is described. The intramolecular ring-opening reaction of activated aziridines proceeds smoothly 
under mild reaction conditions. During the course of the reactions, the relative configuration of aziridines was 
transferred successfully to the respective pyrrolidinones. The configurations ofthe pyrrolidinones were confirmed 
by X-ray analysis and 2D NOESY NMR studies. The same type of intramolecular ring-opening reaction also took 
place with epoxide analogues. In the case of N-Boc aziridines, bicyclic aziridines were obtained by altering the 
reaction conditions. The 4,5-cis-pyrrolidinone could be synthesized from the same starting material S by a two- 
step reaction using hydriodic acid and subsequent treatment with NaOEt. 
A variety of ethyl or methyl 3-alkylaziridine-2-carboxylates are readily available as starting materials by 
reported methods implying that this methodology has, in principle, a wide scope. 4
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EXPERIMENTAL SECTION 
Proton magnetic resonance spectra were measured on a Bruker WH-90, Bruker AC-100 or a Bruker AM- 
400 spectrometer. Chemical shift values are reported as k-values relative to tetramethylsilane as an internal 
standard. Mass spectra were obtained with a double focussing VG 7070E spectrometer. IR spectra were recorded 
on a Perkin-Elmer 298 infrared spectrophotometer. Melting points were measured with a Reichert Thermopan 
microscope and are uncorrected. Recrystallizations were carried out using hexane-EtOAc unless tated otherwise. 
GLC was conducted with a Hewlett-Packard HP 5890 gas chromatograph, using a capillary column (25m) of 
HP-I, and nitrogen at 2 ml/min (0.5 atm) as the carrier gas. Commercial n-BuLi solution in hexane (ca. 1.6M) 
was purchased from Merck. Hexane was distilled from calcium hydride. Diethyl ether (Et20) was pre-dried over 
calcium chloride, then distilled from calcium hydride and again from sodium hydride. Tetrahydrofuran was 
freshly distilled from lithium aluminum hydride. 1,2-Dimethoxyethane wasdistilled from sodium hydride. 
Acetonitrile was distilled from phosphorus pentoxide. N,N,-Dimethylformamide (DMF) was purified first by 
azeotropic distillation with benzene, and, after treatment with barium oxide, it was distilled in vacuo  under 
nitrogen. All other solvents were obtained commercially and used without further purification. Thin-layer 
chromatography (TLC) was performed on silica gel F-254 plates (thickness 0.25 mm). Spots were visualized 
with a UV hand lamp, K2Cr207 solution in diI.H2SO4 or C12-TDM. 19 Column chromatography was carried out 
using silica 60H (for flash chromatography, Merck, art. nr. 7736) or silica 60 (Merck, art. hr. 7734). 
Standard procedure for preparation of aziridinecarboxamides: trans-l .(tert- 
Butoxycarbonyl)-3-hexylaziridine-2-carbonylaminomalonic cid diethylester (5). All the l-(tert- 
butoxycarbonyl)-3-hexylaziridine-2-carboxamides were prepared from the corresponding 3-hexylaziridine-2- 
carboxylic acid methyl (or ethyl) esters 3 according to this procedure: To a solution of 3 (I .0 g; 5.4 retool) in dry 
CH2C12 (6 mL) under argon were added 4-(dimethylamino)pyridine (1.6 g; 14 mmol) and di-tert-butyl 
dicarbonate (2.9 g, 14 mmol). The solution was stirred at room temperature for 2h, quenched with saturated 
aqueous NH4CI solution (25 mL), poured into water, and extracted with ether (3 x 50 mL). The combined 
extracts were washed with saturated aqueous KHSO4 solution, saturated aqueous Na2CO3 solution and brine, 
dried (MgSO4), filtered, and concentrated in vacuo.  Chromatography (silica, hexane-EtOAc (7:1 )) of the residue 
gave the N-Boc derivative (1.5 g, 97%). The pure product (0.77 g, 2.7 mmol) was dissolved in THF (14 mL) 
and treated with a 1.0 N aqueous olution of lithium hydroxide (5.4 mL). The mixture was stirred overnight at 
room temperature and then acidified with dilute H2SO4 to pH 3 and extracted with Et20 (3 x 30 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo  to give N-(tert- 
butoxycarbonyl)-3-hexylaziridine-2-carboxylic acid (0.72 g, 98%) as a colorless oil. The acid was converted into 
5 without further purification by using dicyclohexylcarbodiimide (DCC) as a condensing a ent. The acid (0.69 g, 
2.5 retool), diethyl aminomalonate 20 (0.44 g, 2.5 mmol) and l-hydroxybenzotriazole (0.38 g, 2.5 mmol) were 
dissolved in EtOAc (25 mL). The solution was stirred and cooled in an ice bath and then treated with DCC (0.57 
g, 2.8 retool). The mixture was stirred for one hour at 0 °C and then overnight at room temperature. N,N ' -  
Dicyclohexylurea which separated was removed by filtration. The organic filtrate was washed with a 10% 
solution of citric acid in water (100 mL) and brine, dried (MgSO4), filtered, and concentrated in vacuo.  
Chromatography (silica, hexane-EtOAc (5:1)) gave 5 (0.91 g, 85%). 
Ethyl trans-l-(tert-butoxycarbonyl)-3-hexylaziridine-2-carboxylate. Oil; IR (CC14) 2920, 
1740, 1530, 1310, 1150 cml ;  1H NMR (CDC13) ~ 0.88 (br. t, 3H, CH3(CH2)5), 1.23 - 1.46 (m, 22H, 
CH3(CH2)5, OCH2CH3, C(CH3)3), 2.7 - 2.82 (m, 2H, CHNCH), 4.21+4.23 (2xq, J = 7.2 Hz, 2H, 
OCH2CH3). HRMS (M+I)+; Calcd for C16H30NO4:300.2175 ; Found: 300.21761. 
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trans.l.(tert-Butoxycarbonyi).3-hexylaziridine-2-carbonylaminomalonic acid diethyl- 
ester (5). Oil; IR (CCI4) 3400, 2930, 1760, 1730, 1690, 1500 cm-1; IH NMR (CDCI3) 8 0.88 (br t, 3H, 
CH3(CH2)5), 1.22 - 1.47 (m, 25H, CH3(CH2)5, 2xOCH2CH3, C(CH3)3)), 2.5 - 2.7 (m, 1H, Hex-CHN), 2.83 
(d, J = 2.9 Hz, 1H, NCHCO), 4.24 +4.26 (2xq, J = 7.1 Hz, 4H, 2xOCH2CH3), 5.15 (d, J = 7.4 Hz, IH, 
NHCH), 7.06 (d, J = 7.4 Hz, IH, NH). HRMS (M)+; Calcd for C21H36N207: 428.2522; Found: 428.25273. 
Ethyl trans.3.hexyl-l-(toluene-4-suifonyi)aziridine-2-carboxylate. T  a solution of 3 (1.3 g, 
6.5 mmol) dissolved in dry CH2C12 (33 mL) and triethylamine (1.8 mL, 13 mmol), a catalytic amount of 4- 
dimethylaminopyridine a d tosyl chloride (1.9 g, 9.8 mmol) were added sequentially under argon at 0 °C. After 
30 min, the mixture was allowed to warm to room temperature, and then stirred for 2h at this temperature. The 
mixture was poured into a mixture of Et20 (50 mL) and brine (100 mL), and extracted with Et20 (3 x 40 mL). 
The combined organic extracts were washed with brine, dried (MgSO4), filtered, and concentrated in vacuo. The 
residue was purified by column chromatography (silica, hexane-EtOAc (10:1)) to give ethyl N-tosyl 
aziridinecarboxylate (2.1 g, 92%). mp. 63.5-64 oC; IR (CC14) 3060, 3030, 2955, 2925, 2855, 1740, 1595, 
1460, 1445, 1380, 1370, 1335, 1305, 1290, 1185, 1165, 1090, 1035, 920, 705, 690, 685, 635 cm-l; 1H NMR 
(CDC13) ~ 0.9 (br t, 3H, CH3(CH2)5), l . l - l .7  (t+m, l lH,  CH3(CH2)4CH2, OCH2CH3), 1.95 (m, 2H, 
CH3(CH2)4CH2), 2.4 (s, 3H, PhCH3), 3.05 (m, 1H, Hex-CHN), 3.25 (d, J = 3.5 Hz, IH, NCHCO), 4.15 (q, 
2H, OCH2CH3), 7.3 (d, J = 7.5 Hz, 2H, 3, 5-Ph), 7.85 (d, J = 7.5 Hz, 2H, 2, 6-Ph). MS (CI): m/e (relative 
intensity) 354 (19, M+I), 308 (6), 280 (100), 256 (13), 224 (5), 198 (63), 183 (54), 172 (8), 155 (I 1), 137 (9), 
124 (10), 109 (13), 91 (3), 55 (15), 43 (41). Anal. Calcd. for C18H27NO4S (353.482): C, 61.16; H, 7.70; N, 
3.96; Found: C, 61.42; H, 7.72; N, 4.02. 
3-Hexyl-l-(toluene-4-sulfonyl)aziridine-2-carbonylaminomalonic acid diethyl ester (4). 
This amino-malonic acid diethylester was prepared from ethyl N-tosyl-aziridinecarboxylate according to the 
standard method for N-Boc-aziridinecarboxamide in 92% yield, oil; IR (CC14) 3400, 2920, 1755, 1690, 1500, 
1340 cm-l; IH NMR (CDCI3) 8 0.89 (br t, 3H, CH3(CH2)5), 1.15-1.70 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 
2.44 (s, 3H, PhCH3), 2.8-3.0 (m, 1H, Hex-CHN), 3.35 (d, J = 4.0 Hz, 1H, NCHCO), 4.17+4.20 (2xq, J = 
7.1 Hz, 4H, 2xOCH2CH3), 4.96 (d, J = 7.3 Hz, 1H, NHCH), 6.8 (d, J = 7.5 Hz, 1H, NH), 7.35 (d, J = 8.4 
Hz, 2H, 3, 5-Ph), 7.88 (d, J -- 8.3 Hz, 2H, 2, 6-Ph). HRMS (M)+; Calcd for C23H34N207S: 482.2087; Found: 
482.20862. 
Intramolecular ring opening reactions of aziridine (or oxirane)carboxamides : 
Method A; A representative procedure using NaOEt: N-Boc-aziridinecarboxamide 5 (0.77 g, 1.8 retool) 
was dissolved in absolute EtOH (50 mL), and a few drops of sodium ethoxide (1.3M in EtOH) were added under 
argon at room temperature. The reaction mixture was stirred overnight, hen concentrated in vacuo. The residue 
was purified by column chromatography (silica, hexane-EtOAc (1:1)) to give pyrrolidinone 7 (0.60 g, 78%). 
Method B; A procedure using lithium diisopropylamide: N-Tosyl-aziridinecarboxamide 4 (0.42 g, 0.87 
mmol) dissolved in dry THF (5 mL) was added under argon to lithium diisopropylamide (LDA) solution (33 mL, 
0.029 M in THF) cooled at -78 oC. The mixture was stirred at -78 oC for 30 rain at 0 oC for 2 h, and then 
allowed to warm to room temperature and stirred overnight and then treated with saturated aqueous NH4CI 
solution (10 mL), water, and extracted with EtOAc (3 x 40 mL). The combined organic extracts were washed 
with brine, dried (MgSO4), filtered and concentrated in vacuo. Column chromatography (silica,hexane-EtOAc 
(1:1)) gave pyrrolidinone 6 (0.13 g, 31%). 
Method C; A procedure using pyridine: Pyridine (0.54 mL, 7.0 mmol) was added under argon to a 
chloroform solution (0.35 mL) of 4 (0.25 g, 0.52 mmol) at room temperature. The mixture was stirred overnight 
and then treated with ice/water. The mixture was extracted with EtOAc (3x 15 mL), and the combined organic 
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extracts were washed with dil. aqueous CuSO4 solution (3x 25 mL), brine, dried (MgSO4), filtered and 
concentrated in vacuo. Column chromatography (silica, hexane-EtOAc (3:!) to (1:1)) of the residue gave 6 (0.10 
g, 40%) and 4 (0.08 g, 32%). 
trans-3-(T••uene-4-su•f•ny•)amin•-4-hexy•-5•5-di(eth•xycarb•nyl)pyrr•lidin-2••ne (6). 
rap. 78 -80 °C; IR (CC14) 3420, 3300, 2920,1735, 1540, 1250 cm-l; 1H NMR (CDCI3) 8 0.90 (br t, J = 6.0 Hz, 
3H, CH3(CH2)5), 1.1-1.7 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 2.3 (s, 3H, PhCH3), 2.6-2.8 (m, 1H, Hex- 
CH), 4.0 (dd, J = 9.0, 10 Hz, IH, CHNH), 4.29+4.31 (2xq, J = 7 Hz, 4H, 2xOCH2CH3), 5.7 (br d, J = 9 Hz, 
lH, NH-Ts), 6.8 (br s, 1H, NHCO), 7.3 (d, J = 9 Hz, 2H, 3, 5-Ph), 7.8 (d, J = 9 Hz, 2H, 2, 6-Ph). Anal. 
Calcd. for C23H34N207S: C, 57.24; H, 7.10; N, 5.80; S, 6.64; Found: C, 57.35; H, 7.07; N, 5.79; S, 6.75. 
t rans-3- ( ter t -But•xycarb•ny l )amin•-4-hexy l -5•5-d i (eth•xycarb•ny l )pyrr• l id in -2-•ne (7). 
rap. 144-145 °C; IR (CC14) 3380, 3200, 2920, 1720, 1500, 1370 cm-1; IH NMR (CDCI3) 8 0.87 (t, J = 6.8 Hz, 
3H, CH3(CH2)5), 1.25-1.51 (m, 24H, C(CH3)3, CH3(CH2)4CHH, 2xOCH2CH3), 1.71-1.80 (m, 1H, 
CH3(CH2)4CHH), 2.6-2.8 (m, 1H, Hex-CH), 4.23-4.32 (m, 5H, CHNH, 2xOCH2CH3), 4.92 (d, J = 8.9 Hz, 
IH, NH-CO2t-Bu), 6.55 (br s 1H, NHCO). Anal.Calcd for C21H36N207: C, 58.86; H, 8.47; N, 6.54; Found: 
C,58.81; H, 8.42; N, 6.56. 
2-(6-Hexyl-2,4-dioxo-l ,3-diaza-bicyclo[3,1,0]hex-3-yl)malonic acid diethyl ester (8). N- 
Boc-aziridinecarboxamide 5 (0.50 g, 1.2 mmol) dissolved in dry THF (5 mL) was added under argon to lithium 
diisopropylamide solution (30 mL, 0.088M in THF) cooled to -78 °C. The mixture was stirred at -78 oC for 30 
rain and at 0 oC for 2.5h. The reaction mixture was then treated with saturated aqueous NH4C1 solution (10 mL), 
water, and extracted with EtOAc (3 x 40 mL). The combined organic extracts were washed with brine, dried 
(MgSO4), filtered and concentrated in vacuo. Column chromatography (silica, hexane-EtOAc (3:1)) of the residue 
gave bicyclic aziridine 8 (0.31 g, 73%). oil; IR (CC14) 2920, 1795, 1740, 1390, 1250, 1180 cm-1; IH NMR 
(CDCI3) 8 0.80-1.0 (br t, 3H, CH3(CH2)5), 1.23-1.80 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 2.8-2.9 (m, 1H, 
Hex-CH), 3.22 (d, J = 3.1 Hz, 1H, NCHCO), 4.29 (q, J = 6.9 Hz, 4H, 2xOCH2CH3), 5.10 (s, 1H, 
CH(CO2Et)2). HRMS (M)+; Calcd for CITH26N206:354.1791; Found: 354.17886. 
Ethyl t rans - l - ( te r t -butoxycarbony l ) -3 -buty laz i r id ine -2 -carboxy la te .  4 Oil; IR (CCIa) 2960, 
1730, 1520, 1310, 1225, 1150 cm-l; IH NMR (CDC13)8 0.89 (brt, 3H, CH3(CH2)3), 1.2-1.6 (m, 18H, 
CH3(CH2)3, t-Bu, OCH2CH3), 2.7-2.85 (m, 2H, CHNCH), 4.21+4.24 (2xq, J = 7.2 Hz, 2H, OCH2CH3). 
HRMS (M-t-Bu) +, Calcd for C10HI8NO4: 216.1236; Found: 216.12381. 
l-(tert-Butoxycarbonyl)-3-butylaziridine-2-carbonylaminoacetophenone (9). Ethyl 3- 
butylaziridine-2-carboxylate 4 was converted into the corresponding N-Boc-aziridinecarboxylic acid in the same 
manner as described for 5 in 71% yield. A stirred, cooled (0 °C) mixture of 1-(tert-butoxycarbonyl)-3- 
butylaziridinecarboxylic acid (0.60 g, 2.5 mmol) and iso-butyl chloroformate (0.34 mL, 2.8 retool) in dry THF 
(25 mL) was treated with triethylamine (1.0 mL, 7.5 mmol) and stirred at the same temperature and after lh c~- 
amino-acetophenone hydrogen chloride (0.47 g, 2.8 retool) was added. The reaction mixture was set aside at 0 
°C for 1 h, and then allowed to attain room temperature overnight. The reaction mixture was treated with saturated 
aqueous NH4CI solution (10 mL), water, and extracted with EtOAc (3 x 40 mL). The combined organic extracts 
were washed with a 10% aqueous citric acid solution, saturated aqueous NaHCO3 solution, brine, dried 
(MgSO4), filtered and concentrated in vacuo. Column chromatography (silica, hexane-EtOAc (3:1)) of the residue 
gave 9 (0.55 g, 61%): mp. 137 - 138 oC; IR (CC14) 3400, 2960, 1720, 1675, 1480, 1160 cm-1; IH NMR 
(CDC13) 8 0.92 (m, 3H, CH3(CH2)3), 1.2-1.8 (m, 15H, CH3(CH2)3, t-Bu), 2.58-2.76 (m, 1H, Bu-CH), 2.86 
9918 I. Ft~AKI et al. 
(d, J = 2.8 Hz, IH, NCHCO), 4.76 (d, J = 4.5 Hz, 2H, NHCH2CO), 7.17 (br t, IH, NH), 7.45-7.67 (m, 3H, 
3, 4, 5-Ph), 7.88-8.05 (m, 2H, 2, 6-Ph). Anal. Calcd. for C20H28N204: C, 66.64; H, 7.83; N, 7.77; Found: C, 
66.63; H, 7.65; N, 7.77. 
(6-Butyl -2,4-dioxo- l ,3-diaza-bicycio[3.1.0]hex-3-yl)acetophenone (13). A stirred solution 
of N-Boc-aziridinecarboxamide 9 (0.30 g, 0.84 mmol) in dry THF (25 mL) was treated with a catalytic amount 
of potasium tert-butoxide and then set aside at room temperature for 6h, and then treated with a dilute citric acid 
solution in water, and extracted with EtOAc (3 × 40 mL). The combined organic extracts were washed with 
saturated aqueous NaHCO3 solution, brine, dried (MgSO4), filtered and concentrated in vacuo. Column 
chromatography of the residue (silica gel, hexane-EtOAc (3:1)) gave bicyclic aziridine 13 (0.24 g, 99%) as an oil; 
IR (CC14)2920, 1790, 1725, 1700, 1410, 1220 cm-l; IH NMR (CDCI3)50.92 (brt, 3H, CH3(CH2)3), 1.1-1.9 
(m, 6H, CH3(CH2)3), 3.08-3.30 (m, 2H, CHNCH), 4.80 (s, 2H, NCH2Ph), 7.32-7.80 (m, 3H, 3, 4, 5-Ph), 
7.80-8.02 (m, 2H, 2, 6-Ph). HRMS (M)+; Calcd. for CI6H18N203: 286.1317; Found: 286.13169. 
1-(tert-Butoxycarbonyl)-3-hexylaziridine-2-carbonylaminoacetic acid methyl ester (10). A 
stirred, cooled (0 °C) mixture of trans- l-(tert-Butoxycarbonyl)-3-hexylaziridine-2-carboxylic cid and iso-butyl 
chloroformate (0.35 mL, 2.9 retool) in dry THF (26 mL) was treated with triethylamine (1.1 mL, 7.8 retool) and 
after lh with glycine methyl ester hydrogen chloride (0.36 g, 2.9 mmol). The mixture was then stirred a further 
l h and then at room temperature overnight. The resulting mixture was treated with saturated aqueous NH4CI 
solution ( l0 mL), extracted with EtOAc and the combined organic extracts were washed with dilute aqueous citric 
acid, saturated aqueous NaHCO3, brine, dried (MgSO4), filtered, and concentrated in vacuo. Column 
chromatography of the residue (silica gel, hexane-EtOAc (2:1)) gave 10 as white crystals (0.63 g, 71%): rap. 92 
- 93 oC; IR (CCI4) 3420, 2930, 1750, 1725, 1690, 1368, 1160 cm-1; IH NMR (CDCI3) 6 0.88 (br t, 3H, 
CH3(CH2)5), 1.20-1.60 (m, 19H, CH3(CH2)5, t-Bu), 2.54-2.72 (m, 1H, Hex-CH), 2.81 (d, J = 2.9 Hz, IH, 
NCHCO), 3.76 (s, 3H, OCH3), 4.02+4.05 (2xd, J = 5.4 Hz, 2H, NHCH2CO), 6.6 (br t, IH, NH). Anal. 
Calcd. for C17H30N205: C, 59.63; H, 8.83; N, 8.18; Found: C, 59.74; H, 8.95; N, 8.08. 
(6-Hexyi-2,4-dioxo-l,3-diaza-bicycio[3.1.0]hex-3-yl)acetic acid methyl ester (14). A 
stirred solution of N-Boc-aziridinecarboxamide 10 (0.61 g, 1.8 mmol) in MeOH (52 mL) was treated with a few 
drops of NaOMe (1.3M in MeOH), stirred at room temperature overnight and then concentrated in vacuo. 
Column chromatography of the residue (silica, hexane-EtOAc (3:1)) gave 14 (0.25 g, 52%) and unreacted 10 
(0.18 g, 30%): oil; IR (CC14) 2930, 1795, 1760, 1735, 1415, 1230 cm-1; IH NMR (CDCI3) 6 0.89 (br t, 3H, 
CH3(CH2)5), 1.2-1.8 (m, 10H, CH3(CH2)5), 2.8-3.0 (m, IH, Hex-CH), 3.20 (d, J = 3.1 Hz, 1H, NCHCO), 
3.76 (s, 3H, OCH3), 4.15 (s, 2H, NCH2). HRMS (M+I)+; Calcd. for CI3H21N204: 269.1501; Found: 
269.14999. 
t rans .N-Benzy l . l - ( te r t .butoxycarbony l ) .3 .hexy laz i r id ine .2 .carhoxamide  (11). Using the 
same procedure as for 9, trans-N-Boc-3-hexylaziridine-2-carboxylic acid (0.47 g, 1.7 mmol) was converted into 
11 using iso-hutyl chloroformate (0.26 mL, 2.0 mmol) as a condensing agent (0.61 g, 99% yield): oil; IR (CCI4) 
3400, 2920, 1725, 1685, 1550, 1250 cm-l; 1H NMR (CDCI3) 8 0.78-1.0 (br t, 3H, CH3(CH2)5), 1.18-1.75 
(m, 19H, CH3(CH2)5, t-Bu), 2.48-2.69 (m, 1H, Hex-CH), 2.82 (d, J = 3.0 Hz, IH, NCHCO), 4.42+4.44 
(2xd, J = 5.9 Hz, 2H, NHCH2), 6.48 (br t, 1H, NH), 7.16-7.50 (m, 5H, Ph). HRMS (M+I)+; Calcd. for 
C21H37N203: 361.2491; Found: 361.24992. 
(6-Hexyl.2,4-dioxo- l ,3-diaza-bicyclo[3.1.0]hex-3-yl)methylbenzene (15). A stirred, cooled 
(0 oC) solution of N-Boc-aziridinecarboxamide 11 (0.35 g, 0.97 mmol) in dry THF (10 mL) was treated with a 
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catalytic amount of potassium tert-butoxide, stirred at 0 °C for 2.5h, and then at room temperature overnight. The 
reaction mixture was treated with a 10% aqueous olution of citric acid (10 mL), extracted with EtOAc (3 x 25 
mL), and the combined organic extracts washed with 10% aqueous citric acid, aqueous aturated NaHCO3 and 
brine, dried (MgSO4), filtered and concentrated in vacuo. Column chromatography of the residue (silica, hexane- 
EtOAc (7:1)) gave 15 as a white solid (0.18 g, 65%), which was, then recrystallized from pet.-ether (60-80): mp. 
55-56 oC; IR (CC14) 2920, 1785, 1720, 1390, 1340 cm-1; IH NMR (CDCI3)~ 0.72-1.08 (br t, 3H, 
CH3(CH2)5), 1.08-1.80 (m, 10H, CH3(CH2)5), 2.36-2.60 (m, IH, Hex-CH), 3.10 (d, J = 3.0 Hz, 1H, 
NCHCO), 4.52 (s, 2H, NCH2Ph), 7.20-7.60 (m, 5H, Ph). Anal. Calcd. for CI7H22N202: C, 71.30; H, 7.74; 
N, 9.78: Found: C, 71.42; H, 7.56; N, 9.61. 
Methyl trans-l-(tert-butoxycarbonyi)-3-benzylaziridine-2-carboxylate 4 Oil; IR (CC14) 2590, 
1750, 1730, 1370, 1315, 1155 cm-l; IH NMR (CDCI3) 8 1.43 (s, 9H, t-Bu), 2.69-3.15 (m, 4H, CHNCH, 
CH2Ph), 3.73 (s, 3H, OCH3), 7.20-7.35 (m, 5H, Ph). HRMS (M)+; Calcd. for CI5H21NO4: 291.1470; Found: 
291.14695. 
trans-l-(tert-Butoxycarbonyl)-3-benzylaziridine-2.carbonylaminoacetophenone (12). 
Using a similar procedure as described for 9, N-Boc-aziridinecarboxamide 12 was prepared from N-Boc 
aziridine methyl ester (0.68 g, 2.3 mmol) from the corresponding carboxylic acid (0.57 g, 89% yield) using iso- 
butyl chloroformate as the condensing agent in 61% total yield: mp. 135.5-136.5 oC; IR (CC14) 3310, 1700, 
1650, 1565, 1320 cm-l; 1H NMR (CDCI3) ~ 1.0-1.8 (s, 9H, t-Bu), 2.7-3.2 (m, 4H, CHNCH, CH2Ph), 4.76 
(d, J = 4.5 Hz, 2H, CH2COPh), 7.0-7.7 (m, 9H, NH, aromatic-H), 7.8-8.1 (m, 2H, Ph). Anal. Calcd. for 
C23H26N204: C, 70.03; H, 6.64; N, 7.10; Found: C, 69.73; H, 6.62; N, 7.22. 
[6-(Benzyl)-2,4-dioxo-l,3-diaza-bicycio[3.1.0]hex-3-yl]acetophenone (16). To a stirred 
cooled (0 oC) solution of N-Boc-aziridinecarboxamide 12 (0.34 g, 0.86 mmol) in dry THF (25 mL) was added a 
catalytic amount of potassium tert-butoxide. The mixture was stirred at 0 °C for 3.5h, then at room temperature 
for 2.5h. The reaction mixture was treated with a 10% aqueous citric acid solution, extracted with EtOAc (3 x 40 
mL) and the combined organic extracts washed with saturated aqueous NaHCO3 and brine, dried (MgSO4), 
filtered, and concentrated in vacuo. Column chromatography of the residue (silica, hexane-EtOAc (3:1)) gave 16 
(0.24 g, 87%): oil; IR (CC14) 3015, 2930, 1790, 1725, 1700, 1410, 1220 cm-1; 1H NMR (CDCI3) 8 3.03 (d, J 
= 5.4 Hz, 2H, CHCH2Ph), 3.24 (d, J = 2.6 Hz, 1H, NCHCO), 3.32-3.57 (m, 1H, CHCH2Ph), 4.78 (s, 2H, 
COCH2Ph), 7.20-7.76 (m, 8H, 2xPh), 7.76-8.00 (m, 2H, Ph). HRMS (M)+; Calcd. for CI9H16N203: 
320.1161; Found: 320.11574. 
Methyl cis.3-hexylaziridine-2-carboxylate. M thyl cis-3-hexyloxiranecarboxylate was prepared 
according to a literature method via hydrogenation using the Lindlar catalyst: 4, 21 oil; IR (CC14) 2920, 1760, 
1735, 1440, 1200 cm-l; 1H NMR (CDCI3) 5 0.88 (m, 3H, CH3(CH2)5), 1.1-1.8 (m, 10H, CH3(CH2)5), 3.1- 
3.3 (m, 1H, Hex-CHO), 3.54 (d, J = 4.5 Hz, 1H, OCHCO), 3.80 (s, 3H, OCH3). A solution of methyl cis-3- 
hexyloxiranecarboxylate (1.1 g, 5.9 mmol), NaN3 (1.2 g, 18 mmol), and NH4CI (0.94 g, 18 mmol) in MeOH 
(28 mL) was heated under reflux for 24h, and then concentrated in vacuo. The residue was triturated with ether 
and brine. The organic layer was washed with brine, dried (MgSO4), filtered and concentrated in vacuo. Column 
chromatography of the residue (silica, hexane-EtOAc (4:1)) gave an inseparable mixture of two isomers (1.2 g, 
89%, ratio 3.6:1 by GC). The mixture of the isomers (0.40 g, 1.7 mmol) in N,N-dimethylformamide (40mL) 
was treated with PPh3 (0.50 g, 1.9 mmol) at room temperature with stirring. The mixture was stirred for 3 days 
at room temperature and then heated under eflux for 4h. The cooled reaction mixture was diluted with ether (150 
mL), and the organic solution washed with brine, dried (MgSO4), filtered and concentrated in vacuo. Column 
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chromatography of the residue (silica, hexane-EtOAc (3:1)) gave methyl cis-3-hexylazirid~ne-2-carboxylate (0.08 
g, 25%): oil; IR (CC14) 3260, 2920, 1725, 1440, 1380, 1200 cm-1; IH NMR (CDC13) 8 0.88 (br t, 3H, 
CH3(CH2)5), 1.t-l.7 (m, l lH,  NH, CH3(CH2)5), 2.1-2.3 (m, 1H, Hex-CH), 2.66 (d, J = 6 Hz, 1H, NCH), 
3.77 (s, 3H, OCH3). HRMS (M+I)+; Calcd. for C15H28NO4: 286.2018; Found: 286.20194. 
Methyl cis-l-(tert-butoxycarbonyl)-3-hexylaziridine-2-carboxylate. Using th  standard 
procedure, cis-N-Boc-aziridinecarboxylic acid methyl ester was obtained in 65% yield: oil; IR (CCI4) 2920, 
1755, 1720, 1545, 1250, 1000 cm-l; 1H NMR (CDCI3) 8 0.88 (br t, 3H, CH3(CH2)5), 1.1-1.7 (m, 19H, 
CH3(CH2)5, t-Bu), 2.5-2.7 (m, 1H, Hex-CH), 3.12 (d, J = 6.7 Hz, 1H, NCH), 3.77 (s, 3H, OCH3), HRMS 
(M+I)+; Calcd. for C21H37N207: 429.2601; Found: 429.25973. 
cis-l-(tert-Butoxycarbonyl)-3-hexylaziridine-2-carbonylamino-malonic acid diethyl ester 
(17). Cis-N-Boc-aziridinecarboxylic a id methyl ester was converted into the cis-aziridinecarboxamide 17in 
45% yield by a method similar to that used for trans-N-Boc-aziridinecarboxamide 5: oil; IR (CC14) 3420, 2930, 
1760, 1725, 1500, 1160 cm-1; 1H NMR (CDCl3) 6 0.88 (m, 3H, CH3(CH2)5) 1.1-1.8 (m, 25H, CH3(CH2)5, t- 
Bu, 2xOCH2CH3), 2.46-2.72 (m, 1H, Hex-CH), 3.04-3.25 (m, IH, NCH), 4.27 (q, J = 7.1 Hz, 4H, 
2xOCH2CH3), 5.01-5.19 (br d, IH, CH(CO2Et)2), 7.4 (br d, 1H, NH). HRMS (M+I)+; Calcd. for 
C21H37N207: 429.2601; Found: 429.25973. 
3•4-cis-3-(tert-But•xycarb•nyl)amin•-4-hexyl-5•5-di(eth•xycarb•nyl)pyrr•lidin-2-•ne 
(18). A stirred cooled (0 oC) solution of aziridine 5 (0.64 g, 1.5 mmol) in acetone (15 mL) was treated with 
hydriodic acid ( 1.5 retool). The mixture was stirred for 3h at this temperature, then treated with water. The solid 
produced was filtered and the filtrate cake washed with water. The solid was dried in vacuo to give the crude 
product (0.49 g, 59%). The crude product without further purification was dissolved in absolute thanol (15 mL) 
and treated with sodium ethoxide/ethanol (1.3 mmol) and stirred overnight at room temperature. The resultant 
mixture was treated with saturated aqueous NH4CI solution (30 mL), concentrated in vacuo and the residue 
extracted with EtOAc (3x 40 mL). The combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo. Column chromatography of the residue (silica, hexane-EtOAc (2:1) to (1:1 )) 
gave cis-pyrrolidinone 18 (0.10 g,16%) and trans-pyrrolidinone 7 (0.09 g, 15%): mp. 109-110 oC; IR (CCl4) 
3420, 2920, 1705, 1485, 1365cm-1; 1H NMR (CDCI3) 8 0.87 (t, J = 6.4 Hz, 3H, CH3(CH2)5), 1.2-1.6 (m, 
25H, CH3(CH2)5, t-Bu, 2xOCH2CH3), 2.9-3.0 (m, 1H, Hex-CH), 4.2-4.3 (m, 4H, 2xOCH2CH3), 4.58 (dd, J 
= 8.4, 9.2 Hz, 1H, CHNH), 5.23 (d, J = 9.2 Hz, IH, CHNH), 7.13 (br s, 1H, NHCO); Anal. Calcd. for 
C21H36N207: C, 58.85; H, 8.48; N, 6.54. Found: C, 58.41; H, 8.64; N, 6.43. 
trans-3-Hexyloxirane-2-carbonylaminomalonic acid diethyl ester (19). Ethyl trans-3- 
hexyloxirane-2-carboxylate 5 (2.0 g, 10 retool) in EtOH (100 mL) and H20 (90 mL) was heated under eflux for 
5h in the presence of NaOH (0.80 g, 20 mmol). The reaction mixture was cooled to room temperature, 
concentrated in vacuo, then acidified to pH 3 with dilute H2SO4 and extracted with ether (3x 50 mL). The organic 
layer was extracted with 15% NaOH solution and the aqueous alkaline solution acidified to pH 3 with dilute 
H2SO4, and the mixture was then extracted with ether (3x 50 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo to give trans-3-hexyloxirane-2-carboxylic acid (1.7 g, 99%). A 
solution of the crude product (1.7 g, 9.9 mmol) and diethyl aminomalonate (2.3 g, 11 mmol) in EtOAc (80 mL) 
was treated with dicyciohexylcarbodiimide (DCC) (2.2 g, 11 retool) at 0 oC for lh and overnight at room 
temperature. Then the white precipitate was filtered and washed with EtOAc (5x 20 mL), and the filtrate and the 
washings were combined and washed with saturated aqueous NaHCO3 solution, a 10% aqueous citric acid 
solution, brine, dried (MgSO4), filtered and concentrated in vacuo. Column chromatography (silica, hexane- 
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EtOAc (5:1)) of the residue gave 19 (2.9 g, 88%): mp. 49-50 °C; IR (CC14) 3400, 2930, 1760, 1690, 1500, 
1370 cm-1; IH NMR (CDC13) 8 1.75-1.01 (m, 3H, CH3(CH2)5), 1.1-1.8 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 
2.96-3.19 (m, 1H, Hex-CH), 3.27 (d, J = 2 Hz, 1H, OCHCO), 4.27+4.29 (2xq, J = 7.1 Hz, 4H, 
2xOCH2CH3), 5.14 (d, J = 5.6 Hz, IH, CH(CO2Et)2), 7.04 (d, J = 7.6 Hz, 1H, NH). Anal. Calcd. for 
C16H27NO6: C, 58.34; H, 8.26; N, 4.25; Found: C, 58.81; H, 8.33; N, 4.33. 
trans.5,5-Di(ethoxycarbonyl)-3-hydroxy-4-hexylpyrrolidin-2.one (20). A stirred solution of 
the oxiranecarboxamide 19 (0.40 g, 1.2 mmoi) in EtOH (36 mL) under argon was treated with a catalytic amount 
of NaOEt/EtOH, set aside overnight at room temperature, and then concentrated in vacuo. Column 
chromatography (silica, hexane-EtOAc (3:1)) of the residue gave 19 (0.09 g, 22%) and 20 (0.31 g, 78%): bp. 
227 oC/2.0 mm Hg; IR (CC14) 3540, 3430, 2930, 1740, 1250, 1095 cm-1; 1H NMR (CDC13) 8 0.75-1.08 (br t, 
3H, CH3(CH2)5), 1.10-2.10 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 2.55-2.86 (m, 1H, Hex-CH), 3.86 (br s, 
IH, OH), 4.21 (d, J = 7 Hz, 1H, CHOH), 4.27+4.31 (2xq, J = 7.0 Hz, 4H, 2xOCH2CH3), 7.06 (br s, IH, 
NH). Anal. Calcd. for CI6H27NO6; C, 58.34; H, 8.26; N, 4.25; Found: C, 58.80; H, 8.18; N, 4.67. HRMS 
(M+I)+; Calcd. for C16H28NO6: 330.1916; Found: 330.19166. 
C6H4OCH3), 7.27 (d, J = 9.0 Hz, 2H, 2, 6-C6/-/4OCH3), 7.39 (d, J = 9.0 Hz, 2H, 3, 5-C6H4CH3), 7.75 
(d, J - 8.1 Hz, 2H, 2, 6-C6H4CH3). HRMS (M)+; Calcd. for C30H40OsN2S: 588.2505; Found: 588.2503. 
trans.3.Butyl.oxirane-2-carbonyl-(N-methyl)aminomalonic acid diethyl ester (21). Ethyl 
trans-3-butyloxirane-carboxylate (0.85 g, 4.9 mmol) was hydrolysed with LiOH/H20 (1.0M) using the standard 
method as described for (5). A stirred solution of the oxiranecarboxylic a id (0.60 g, 4.2 retool, 85% yield) thus 
obtained, diethyl (methylamino)malonate (0.79 g, 4.2 mmol) and 1-hydroxybenzotriazole (0.64 g, 4.2 mmol) in 
EtOAc (60 mL) was treated with dicyclohexylcarbodiimide (0.87 g, 4.2 mmol) at 0 °C for lh and at room 
temperature overnight. After standard workup and column chromatography (silica, Hexane-EtOAc (3:1)), 21 
(0.50 g, 38%) was obtained: oil; IR (CCl4) 2960, 1740, 1665, 1465, 1300 cm-1; 1H NMR (CDCI3) ~ 0.8-1.1 
(m, 3H, CH3(CH2)3), 1.2-1.9 (m, 12H, CH3(CH2)3, 2xOCH2CH3), 3.1-3.3 (m, IH, Bu-CH), 3.25 (s, 3H, 
NCH3), 3.48 (d, J = 2.0 Hz, 1H, OCHCO), 4.1-4.4 (m, 4H, 2xOCH2CH3), 5.91 (s, 1H, CH(CO2Et)2). 
HRMS (M) + Calcd for CISH2506N: 315.16819; Found: 315.16821. 
trans-4-Butyl-5,5-di(ethoxycarbonyl),3-hydroxy-l-methylpyrrol idin-2-one (2 ). The V- 
lactam cyclization reaction was carried out following the standard procedure for intramolecular ring opening of 
aziridinecarboxamides (method A) using a catalytic amount of NaOEt/EtOH. After purification by column 
chromatography (silica, Hexane-EtOAc (2:1)), 22 was obtained in 93% yield as an oil; IR (CCl4) 3400, 2960, 
1740, 1720, 1240 cm-l; 1H NMR (CDCI3) ~5 0.91 (t, J = 7.2 Hz, 3H, CH3(CH2)3), 1.25-1.35 (m, 12H, 
CH3(CH2)3, 2xOCH2CH3), 2.6-2.7 (m, IH, Bu-CH), 2.95 (s, 3H, NCH3), 3.7 (br s, IH, OH), 4.08 (d, J = 
10 Hz, 1H, CHOH), 4.27 (q, J = 7.2 Hz, 2H, OCH2CH3), 4.32 (q, J = 7.2 Hz, 2H, OCH2CH3). HRMS 
(M+H) + Calcd. for C15H2606N: 316.17601: Found; 316.17618. Anal. Calcd.: C, 56.95; H, 8.28; N, 4.43; 
Found: C, 57.29; H, 8.28; N, 4.43. 
[trans.3.Hexyl.l.(toluene.4-sulfonyl)aziridine-2-carbonyl(N-benzyl)amino]acetic acid 
ethyl ester (23). Using the standard method as described for (5), by DCC coupling in the presence of l- 
hydroxybenzotriazole (0.37 g, 2.4 retool), trans-1-(toluene-4-suifonyl)-3-hexylaziridine-2-carboxylic cid (0.79
g, 2.4 retool) was condensed with N-benzylglycine ethyl ester (0.52 g, 2.6 retool) to give 23 (1.1 g, 87%): oil; 
IR (CCI4) 2920, 1745, 1670, 1450, 1330, 1160 cm-I; IH NMR (CDCI3) 8 0.7-1.08 (br t, 3H, CH3(CH2)5), 
1.08-2.1 (m, 13H, CH3(CH2)5, OCH2CH3), 2.41 (s, 3H, PhCH3), 3.05-3.40 (m, 1H, Hex-CH), 3.51 (d, J = 
4.2 Hz, 1H, NCHCO), 3.85-4.30 (m, 4H, CH2CO2Et, OCH2CH3), 4.75 (d, J = 3 Hz, 2H, CH2Ph), 7.00-7.46 
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(m, 7H, CH2Ph, 3, 5-C6H4CH3), 7.70-7.94 (m, 2H, 2, 6-C6H4CH3). HRMS (M)+; Calcd. for C27H36N205S: 
500.2345; Found: 500.2344. 
cis-1-Benzyl-[1-(t•luene-4-sulf•nylamin•)-hept-•-yl]-4-eth•xycarb•nylazetidin-2-•ne 
(24). 
Method A (with LDA): Lithium diisopropylamide (0.99 mmol, 0.20M in THF) was added to a stirred 
solution of aziridine 23 (0.45 g, 0.90 mmol) in dry THF (25 mL) under argon cooled to -78 oC. The reaction 
mixture was allowed to warm to 0 oC and then stirred at the same temperature overnight. The reaction mixture 
was treated with 10% aqueous citric acid, extracted with EtOAc (3x 30 mL), the combined organic extracts 
washed with aqueous aturated NaHCO3, brine, dried (MgSO4), filtered and concentrated in vacuo. Column 
chromatography (silica, hexane-EtOAc (3:1)) of the residue gave 23 (0.24 g) and azetidinone 24 (0.03 g, 7%). 
Method B (with tert-BuOK): Aziridinecarboxamide 23 (0.34 g, 0.68 mmol) in dry THF (5 mL) was added 
to a stirred cooled (0 oC) solution of tert-BuOK (0.084 g, 0.75 mmol) in THF (20 mL) under argon, and then 
stirred overnight at 0 oC. The same workup as described in method A was followed to give 23 (0.13 g, 38%) and 
24 (0 07 g, 19%): oil; IR (CC14) 3340, 2920, 1745, 1560, 1350 cm-1; IH NMR (CDCI3) ~i 0.80-0.86 (m, 3H, 
CH3(CH2)5), 1.05-1.6 (m, 13H, CH3(CH2)5, OCH2CH3), 2.41 (s, 3H, C6H4CH3), 3.61 (dd, J = 4.7, 5.9 Hz, 
IH, CHCONBn), 3.69-3.78 (m, 1H, CHNH), 3.95 (d, J = 5.9 Hz, 1H, CHCO), 4.13+4.27 (2s, 1H, 
CHHPh), 4.27+4.31 (2q, J = 4.3 Hz, 2H, OCH2CH3), 4.77+4.92 (2s, IH, CHHPh), 5.13 (d, J = 9.4 Hz, 1H, 
NH), 7.18-7.21 (m, 2H, CH2Ph), 7.26-7.35 (m, 5H, CH2Ph, 3, 5-C6H4CH3), 7.73-7.76 (m, 2H, 2, 6- 
C6H4CH3). HRMS (M)+; Calcd. for C27H36N205S: 500.2345; Found: 500.2345. 
3-(tert-Butoxycarbonylamino)-4-hexyl-5-ethoxycarbonyipyrrolidin-2-one (26). A mixture 
of diester 7 (0.30 g, 0.70 retool), lithium bromide (0.061 g, 0.70 retool), water (0.013 g, 0.70 mmol) in 
dimethyl-2-imidazolidinone (DMI) (7 mL) was heated at 155 oC for 4h. The cooled mixture was poured into 
ice/water and extracted with EtOAc (2x 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Column chromatography (silica, hexane-EtOAc (1:1)) of the residue gave an inseparable 
mixture (1:1 ratio) of monoester 26 (0.16 g, 64%) as an oil: IR (CCI4) 3300, 1720, 1490, 1365, 1170 cm-1; I H 
NMR (CDCI3) ~ 0.88 (t, J = 6 Hz, 3H, CH3(CH2)5), 1.2-1.5 (m, 20H, t-Bu, OCH2CH3, CH3(CH2)4CH2), 
1.6-1.8 (m, 2H, CH3(CH2)4CH2), 2.2-2.3 (m, 0.5H, Hex-CH), 2.4-2.6 (m, 0.5H, Hex-CH), 3.83 (d, J = 7.6 
Hz, 0.5H, CHNHBoc), 4.16-4.28 (m, 3.5H, NHCHCO2Et, CHCHNHBoc, OCH2CH3), 5.06 (d, J = 7.6 Hz, 
0.5H, NHCO), 5.25 (d, J = 8.4 Hz, 0.5H, NHCO), 7.02 (br s, IH, NHBoc); HRMS (M+I)+; Calcd for 
C18H33N205: 357.23895; Found: 357.23866. 
3-(Toluene-4-sulfonylamino)-4-hexyl-5-ethoxycarbonylpyrrolidin-2-one (27), The same 
procedure described for 26 was followed with diester 6 (0.28 g, 0.58 retool). Column chromatography (silica, 
hexane-EtOAc (1:1)) of the crude product gave 27a (0.05 g, 21%) and 27b (0.05 g, 21%) as white solids; each 
solid was recrystallized from CC14. 
(27a) (more mobile): mp. 125-126 oC; IR (CC14) 3300, 2920, 1730, 1450, 1335, 1160 cm-l; IH NMR 
(CDCI3) ~ 0.90 (m, 3H, CH3(CH2)5), 1.2-1.4 (m, 12H, OCH2CH3, CH3(CH2)4CH2), 1.6-1.8 (m, 1H, 
CH3(CH2)4CH2), 2.4 (m, 1H, Hex-CH, and s, 3H, C6H4CH3), 3.7 (dd, J = 7.6, 7.6 Hz, 1H, CHNHTs), 3.84 
(d, J = 7.0 Hz, 1H, CHCO2Et), 4.22 (q, J = 7.0 Hz, 2H, OCH2CH3), 5.68 (d, J = 7.6 Hz, 1H, NHTs), 6.78 
(s, IH, NHCO), 7.30 (d, J = 8.0 Hz, 2H, 3, 5-C6H4CH3), 7.81 (d, J = 8.0 Hz, 2H, 2, 6-C6H4CH3); HRMS 
(M+I)+; Calcd for C20H31N205S: 411.19537; Found: 411.19525. 
(27b) (less mobile): rap. 122-124 oC; IR (CC14) 3200, 1730, 1700, 1460, 1335, 1160 cm-l; 1H NMR 
(CDC13) 6 0.88 (t, J = 6.1 Hz, 3H, CH3(CH2)5), 1.0-1.5 (m, 12H, OCH2CH3, CH3(CH2)4CH2), 1.6-1.8 (m, 
1H, CH3(CH2)4CH2), 2.41 (m, 1H, Hex-CH, and s, 3H, C6H4CH3), 3.85 (d, J = l lHz, 1H, CHCO2Et), 4.12 
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(d, J = 7.2 Hz, 1H, CHNHTs), 4.20 (q, J = 6.9 Hz, 2H, OCH2CH3), 5.52 (br s, 1H, NHTs), 6.40 (br s, 1H, 
NHCO), 7.30 (d, J = 8.3 Hz, 2H, 3, 5-C6H4CH3), 7.80 (d, J = 8.3 az, 2H, 2, 6-C6H4CH3); Anal. Calcd for 
C20H30N205S: C, 58.51; H, 7.37; N, 6.82; S, 7.81; Found: C, 58.74; H, 7.33; N, 6.89; S, 7.66. 
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